Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress

Cell Metabolism

Volumn 12, Issue 5, 2010, Pages 467-482

  Seimon, Tracie A ^a   Nadolski, Marissa J ^a   Liao, Xianghai ^a   Magallon, Jorge ^a   Nguyen, Matthew ^a   Feric, Nicole T ^b   Koschinsky, Marlys L ^b   Harkewicz, Richard ^c   Witztum, Joseph L ^c   Tsimikas, Sotirios ^c   Golenbock, Douglas ^d   Moore, Kathryn J ^e   Tabas, Ira ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF WINDSOR   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; SATURATED FATTY ACID; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; FEMALE; IN VIVO STUDY; LIPID OXIDATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD36; APOPTOSIS; ATHEROSCLEROSIS; ENDOPLASMIC RETICULUM; FATTY ACIDS; GENE DELETION; LIPOPROTEIN(A); LIPOPROTEINS; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NADPH OXIDASE; OXIDATION-REDUCTION; PHOSPHOLIPIDS; REACTIVE OXYGEN SPECIES; TOLL-LIKE RECEPTOR 2;

MUS;

EID: 77958532945     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2010.09.010     Document Type: Article

References (76)

1. O. Adachi, T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function Immunity 9 1998 143 150
2. C. Bergmark, A. Dewan, A. Orsoni, E. Merki, E.R. Miller, M.J. Shin, C.J. Binder, S. Hörkkö, R.M. Krauss, and M.J. Chapman A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma J. Lipid Res. 49 2008 2230 2239
3. E.A. Bey, B. Xu, A. Bhattacharjee, C.M. Oldfield, X. Zhao, Q. Li, V. Subbulakshmi, G.M. Feldman, F.B. Wientjes, and M.K. Cathcart Protein kinase C delta is required for p47phox phosphorylation and translocation in activated human monocytes J. Immunol. 173 2004 5730 5738
4. N.M. Borradaile, X. Han, J.D. Harp, S.E. Gale, D.S. Ory, and J.E. Schaffer Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death J. Lipid Res. 47 2006 2726 2737
5. A. Boullier, P. Friedman, R. Harkewicz, K. Hartvigsen, S.R. Green, F. Almazan, E.A. Dennis, D. Steinberg, J.L. Witztum, and O. Quehenberger Phosphocholine as a pattern recognition ligand for CD36 J. Lipid Res. 46 2005 969 976
6. E. Braunwald Shattuck lecture - cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities N. Engl. J. Med. 337 1997 1360 1369
7. L. Brazier, L. Tiret, G. Luc, D. Arveiler, J.B. Ruidavets, A. Evans, J. Chapman, F. Cambien, and J. Thillet Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study Atherosclerosis 144 1999 323 333 (Pubitemid 29305466)
8. T. Devries-Seimon, Y. Li, P.M. Yao, E. Stone, Y. Wang, R.J. Davis, R. Flavell, and I. Tabas Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor J. Cell Biol. 171 2005 61 73
9. C. Dewas, M. Fay, M.A. Gougerot-Pocidalo, and J. El-Benna The mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway is involved in formyl-methionyl-leucyl-phenylalanine-induced p47phox phosphorylation in human neutrophils J. Immunol. 165 2000 5238 5244
10. J.G. Dickhout, G.S. Hossain, L.M. Pozza, J. Zhou, S. Lhoták, and R.C. Austin Peroxynitrite causes endoplasmic reticulum stress and apoptosis in human vascular endothelium: implications in atherogenesis Arterioscler. Thromb. Vasc. Biol. 25 2005 2623 2629
11. C. Edelstein, D. Pfaffinger, J. Hinman, E. Miller, G. Lipkind, S. Tsimikas, C. Bergmark, G.S. Getz, J.L. Witztum, and A.M. Scanu Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a) J. Biol. Chem. 278 2003 52841 52847
12. G. Endemann, L.W. Stanton, K.S. Madden, C.M. Bryant, R.T. White, and A.A. Protter CD36 is a receptor for oxidized low density lipoprotein J. Biol. Chem. 268 1993 11811 11816
13. E. Erbay, V.R. Babaev, J.R. Mayers, L. Makowski, K.N. Charles, M.E. Snitow, S. Fazio, M.M. Wiest, S.M. Watkins, M.F. Linton, and G.S. Hotamisligil Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis Nat. Med. 15 2009 1383 1391
14. S. Erqou, S. Kaptoge, P.L. Perry, E. Di Angelantonio, A. Thompson, I.R. White, S.M. Marcovina, R. Collins, S.G. Thompson, J. Danesh Emerging Risk Factors Collaboration Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality JAMA 302 2009 412 423
15. C. Erridge, and N.J. Samani Saturated fatty acids do not directly stimulate Toll-like receptor signaling Arterioscler. Thromb. Vasc. Biol. 29 2009 1944 1949
16. B. Feng, P.M. Yao, Y. Li, C.M. Devlin, D. Zhang, H.P. Harding, M. Sweeney, J.X. Rong, G. Kuriakose, and E.A. Fisher The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages Nat. Cell Biol. 5 2003 781 792
17. N.T. Feric, M.B. Boffa, S.M. Johnston, and M.L. Koschinsky Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipoprotein(a)-mediated inhibition of plasminogen activation J. Thromb. Haemost. 6 2008 2113 2120
18. J. Frank, H.K. Biesalski, S. Dominici, and A. Pompella The visualization of oxidant stress in tissues and isolated cells Histol. Histopathol. 15 2000 173 184
19. P.S. Gargalovic, N.M. Gharavi, M.J. Clark, J. Pagnon, W.P. Yang, A. He, A. Truong, T. Baruch-Oren, J.A. Berliner, T.G. Kirchgessner, and A.J. Lusis The unfolded protein response is an important regulator of inflammatory genes in endothelial cells Arterioscler. Thromb. Vasc. Biol. 26 2006 2490 2496
20. M.E. Greenberg, X.M. Li, B.G. Gugiu, X. Gu, J. Qin, R.G. Salomon, and S.L. Hazen The lipid whisker model of the structure of oxidized cell membranes J. Biol. Chem. 283 2008 2385 2396
21. W.R. Hazzard, and W.H. Ettinger Jr. Aging and atherosclerosis: changing considerations in cardiovascular disease prevention as the barrier to immortality is approached in old age Am. J. Geriatr. Cardiol. 4 1995 16 36
22. K. Hoebe, P. Georgel, S. Rutschmann, X. Du, S. Mudd, K. Crozat, S. Sovath, L. Shamel, T. Hartung, U. Zähringer, and B. Beutler CD36 is a sensor of diacylglycerides Nature 433 2005 523 527
23. S.R. Holmer, C. Hengstenberg, H.G. Kraft, B. Mayer, M. Pöll, S. Kürzinger, M. Fischer, H. Löwel, G. Klein, G.A. Riegger, and H. Schunkert Association of polymorphisms of the apolipoprotein(a) gene with lipoprotein(a) levels and myocardial infarction Circulation 107 2003 696 701 (Pubitemid 36222596)
24. K. Hoshino, O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product J. Immunol. 162 1999 3749 3752
25. P. Hu, Z. Han, A.D. Couvillon, and J.H. Exton Critical role of endogenous Akt/IAPs and MEK1/ERK pathways in counteracting endoplasmic reticulum stress-induced cell death J. Biol. Chem. 279 2004 49420 49429
26. A. Ibrahimi, and N.A. Abumrad Role of CD36 in membrane transport of long-chain fatty acids Curr. Opin. Clin. Nutr. Metab. Care 5 2002 139 145
27. D.J. Kennedy, S.D. Kuchibhotla, E. Guy, Y.M. Park, G. Nimako, D. Vanegas, R.E. Morton, and M. Febbraio Dietary cholesterol plays a role in CD36-mediated atherogenesis in LDLR-knockout mice Arterioscler. Thromb. Vasc. Biol. 29 2009 1481 1487
28. E.F. Kenny, and L.A. O'Neill Signalling adaptors used by Toll-like receptors: an update Cytokine 43 2008 342 349
29. M.L. Koschinsky, and S.M. Marcovina Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity Curr. Opin. Lipidol. 15 2004 167 174
30. M.L. Koschinsky, J.E. Tomlinson, T.F. Zioncheck, K. Schwartz, D.L. Eaton, and R.M. Lawn Apolipoprotein(a): expression and characterization of a recombinant form of the protein in mammalian cells Biochemistry 30 1991 5044 5051
31. F.S. Laroux, X. Romero, L. Wetzler, P. Engel, and C. Terhorst Cutting edge: MyD88 controls phagocyte NADPH oxidase function and killing of gram-negative bacteria J. Immunol. 175 2005 5596 5600
32. J.Y. Lee, and D.H. Hwang The modulation of inflammatory gene expression by lipids: mediation through Toll-like receptors Mol. Cells 21 2006 174 185
33. G. Li, M. Mongillo, K.T. Chin, H. Harding, D. Ron, A.R. Marks, and I. Tabas Role of ERO1-α-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis J. Cell Biol. 186 2009 783 792
34. P. Libby Changing concepts of atherogenesis J. Intern. Med. 247 2000 349 358
35. W.S. Lim, J.M. Timmins, T.A. Seimon, A. Sadler, F.D. Kolodgie, R. Virmani, and I. Tabas Signal transducer and activator of transcription-1 is critical for apoptosis in macrophages subjected to endoplasmic reticulum stress in vitro and in advanced atherosclerotic lesions in vivo Circulation 117 2008 940 951
36. X. Liu, T. Ukai, H. Yumoto, M. Davey, S. Goswami, F.C. Gibson 3rd, and C.A. Genco Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids Atherosclerosis 196 2008 146 154
37. D. Lloyd-Jones, R.J. Adams, T.M. Brown, M. Carnethon, S. Dai, G. De Simone, T.B. Ferguson, E. Ford, K. Furie, and C. Gillespie Executive summary: heart disease and stroke statistics - 2010 update: a report from the American Heart Association Circulation 121 2010 948 954
38. J.J. Manning-Tobin, K.J. Moore, T.A. Seimon, S.A. Bell, M. Sharuk, J.I. Alvarez-Leite, M.P. de Winther, I. Tabas, and M.W. Freeman Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice Arterioscler. Thromb. Vasc. Biol. 29 2009 19 26
39. K.S. Michelsen, M.H. Wong, P.K. Shah, W. Zhang, J. Yano, T.M. Doherty, S. Akira, T.B. Rajavashisth, and M. Arditi Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E Proc. Natl. Acad. Sci. USA 101 2004 10679 10684
40. Y.I. Miller, D.S. Worrall, C.D. Funk, J.R. Feramisco, and J.L. Witztum Actin polymerization in macrophages in response to oxidized LDL and apoptotic cells: role of 12/15-lipoxygenase and phosphoinositide 3-kinase Mol. Biol. Cell 14 2003 4196 4206
41. C. Monaco, S.M. Gregan, T.J. Navin, B.M. Foxwell, A.H. Davies, and M. Feldmann Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis Circulation 120 2009 2462 2469
42. K.J. Moore, V.V. Kunjathoor, S.L. Koehn, J.J. Manning, A.A. Tseng, J.M. Silver, M. McKee, and M.W. Freeman Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice J. Clin. Invest. 115 2005 2192 2201
43. A.E. Mullick, P.S. Tobias, and L.K. Curtiss Modulation of atherosclerosis in mice by Toll-like receptor 2 J. Clin. Invest. 115 2005 3149 3156
44. A.E. Mullick, K. Soldau, W.B. Kiosses, T.A. Bell 3rd, P.S. Tobias, and L.K. Curtiss Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events J. Exp. Med. 205 2008 373 383
45. M. Myoishi, H. Hao, T. Minamino, K. Watanabe, K. Nishihira, K. Hatakeyama, Y. Asada, K. Okada, H. Ishibashi-Ueda, and G. Gabbiani Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome Circulation 116 2007 1226 1233
46. M.T. Nguyen, S. Favelyukis, A.K. Nguyen, D. Reichart, P.A. Scott, A. Jenn, R. Liu-Bryan, C.K. Glass, J.G. Neels, and J.M. Olefsky A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways J. Biol. Chem. 282 2007 35279 35292
47. N.J. Nilsen, S. Deininger, U. Nonstad, F. Skjeldal, H. Husebye, D. Rodionov, S. von Aulock, T. Hartung, E. Lien, O. Bakke, and T. Espevik Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36 J. Leukoc. Biol. 84 2008 280 291
48. K. Oka, T. Sawamura, K. Kikuta, S. Itokawa, N. Kume, T. Kita, and T. Masaki Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells Proc. Natl. Acad. Sci. USA 95 1998 9535 9540
49. E.M. Plsson-McDermott, and L.A. O'Neill The potential of targeting Toll-like receptor 2 in autoimmune and inflammatory diseases Ir. J. Med. Sci. 176 2007 253 260
50. Y.M. Park, M. Febbraio, and R.L. Silverstein CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima J. Clin. Invest. 119 2009 136 145
51. E. Pedruzzi, C. Guichard, V. Ollivier, F. Driss, M. Fay, C. Prunet, J.C. Marie, C. Pouzet, M. Samadi, and C. Elbim NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells Mol. Cell. Biol. 24 2004 10703 10717
52. E.A. Podrez, E. Poliakov, Z. Shen, R. Zhang, Y. Deng, M. Sun, P.J. Finton, L. Shan, B. Gugiu, and P.L. Fox Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36 J. Biol. Chem. 277 2002 38503 38516
53. P. Riis Hansen, A. Kharazmi, M. Jauhiainen, and C. Ehnholm Induction of oxygen free radical generation in human monocytes by lipoprotein(a) Eur. J. Clin. Invest. 24 1994 497 499 (Pubitemid 2102513)
54. D.M. Schrijvers, G.R. De Meyer, A.G. Herman, and W. Martinet Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability Cardiovasc. Res. 73 2007 470 480
55. T.A. Seimon, A. Obstfeld, K.J. Moore, D.T. Golenbock, and I. Tabas Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages Proc. Natl. Acad. Sci. USA 103 2006 19794 19799
56. T.A. Seimon, Y. Wang, S. Han, T. Senokuchi, D.M. Schrijvers, G. Kuriakose, A.R. Tall, and I.A. Tabas Macrophage deficiency of p38alpha MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice J. Clin. Invest. 119 2009 886 898
57. J.J. Senn Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes J. Biol. Chem. 281 2006 26865 26875
58. H. Shi, M.V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J.S. Flier TLR4 links innate immunity and fatty acid-induced insulin resistance J. Clin. Invest. 116 2006 3015 3025
59. K. Shimada, T. Murayama, M. Yokode, T. Kita, H. Uzui, T. Ueda, J.D. Lee, and C. Kishimoto N-acetylcysteine reduces the severity of atherosclerosis in apolipoprotein E-deficient mice by reducing superoxide production Circ. J. 73 2009 1337 1341
60. R.L. Silverstein Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36 Cleve. Clin. J. Med. 76 Suppl 2 2009 S27 S30
61. S. Sim, T.S. Yong, S.J. Park, K.I. Im, Y. Kong, J.S. Ryu, D.Y. Min, and M.H. Shin NADPH oxidase-derived reactive oxygen species-mediated activation of ERK1/2 is required for apoptosis of human neutrophils induced by Entamoeba histolytica J. Immunol. 174 2005 4279 4288
62. H.U. Simon, A. Haj-Yehia, and F. Levi-Schaffer Role of reactive oxygen species (ROS) in apoptosis induction Apoptosis 5 2000 415 418
63. L.M. Stuart, J. Deng, J.M. Silver, K. Takahashi, A.A. Tseng, E.J. Hennessy, R.A. Ezekowitz, and K.J. Moore Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain J. Cell Biol. 170 2005 477 485
64. H. Sun, H. Unoki, X. Wang, J. Liang, T. Ichikawa, Y. Arai, M. Shiomi, S.M. Marcovina, T. Watanabe, and J. Fan Lipoprotein(a) enhances advanced atherosclerosis and vascular calcification in WHHL transgenic rabbits expressing human apolipoprotein(a) J. Biol. Chem. 277 2002 47486 47492
65. B. Sun, B.B. Boyanovsky, M.A. Connelly, P. Shridas, D.R. van der Westhuyzen, and N.R. Webb Distinct mechanisms for OxLDL uptake and cellular trafficking by class B scavenger receptors CD36 and SR-BI J. Lipid Res. 48 2007 2560 2570
66. I. Tabas Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency Arterioscler. Thromb. Vasc. Biol. 25 2005 2255 2264
67. O. Takeuchi, S. Sato, T. Horiuchi, K. Hoshino, K. Takeda, Z. Dong, R.L. Modlin, and S. Akira Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins J. Immunol. 169 2002 10 14
68. E. Thorp, G. Li, T.A. Seimon, G. Kuriakose, D. Ron, and I. Tabas Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-/- and Ldlr-/- mice lacking CHOP Cell Metab. 9 2009 474 481
69. R.M. Touyz, G. Yao, and E.L. Schiffrin c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 23 2003 981 987
70. D.A. Trégouët, I.R. König, J. Erdmann, A. Munteanu, P.S. Braund, A.S. Hall, A. Grosshennig, P. Linsel-Nitschke, C. Perret, M. DeSuremain Wellcome Trust Case Control Consortium Cardiogenics Consortium Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease Nat. Genet. 41 2009 283 285
71. R. Virmani, A.P. Burke, F.D. Kolodgie, and A. Farb Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque J. Interv. Cardiol. 16 2003 267 272
72. Y. Wei, D. Wang, F. Topczewski, and M.J. Pagliassotti Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells Am. J. Physiol. Endocrinol. Metab. 291 2006 E275 E281
73. K.J. Williams, and E.A. Fisher Oxidation, lipoproteins, and atherosclerosis: which is wrong, the antioxidants or the theory? Curr. Opin. Clin. Nutr. Metab. Care 8 2005 139 146
74. J. Yu, M. Weïwer, R.J. Linhardt, and J.S. Dordick The role of the methoxyphenol apocynin, a vascular NADPH oxidase inhibitor, as a chemopreventative agent in the potential treatment of cardiovascular diseases Curr. Vasc. Pharmacol. 6 2008 204 217
75. Z. Zhao, M.C. de Beer, L. Cai, R. Asmis, F.C. de Beer, W.J. de Villiers, and D.R. van der Westhuyzen Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner Arterioscler. Thromb. Vasc. Biol. 25 2005 168 173
76. J. Zhou, S. Lhoták, B.A. Hilditch, and R.C. Austin Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice Circulation 111 2005 1814 1821